113 related articles for article (PubMed ID: 25955472)
1. Author reply: To PMID 25442759.
Commons RJ; Hannah R; Currie BJ
Intern Med J; 2015 May; 45(5):591. PubMed ID: 25955472
[No Abstract] [Full Text] [Related]
2. Not only monoclonal antibodies..
Nossent JC
Intern Med J; 2015 May; 45(5):590. PubMed ID: 25955470
[No Abstract] [Full Text] [Related]
3. Melioidosis in a patient on monoclonal antibody therapy for psoriatic arthritis.
Commons RJ; Grivas R; Currie BJ
Intern Med J; 2014 Dec; 44(12a):1245-6. PubMed ID: 25442759
[TBL] [Abstract][Full Text] [Related]
4. Injection site reactions of adalimumab spreading on the trunk in a psoriatic arthritis patient.
Kato Y; Kawakami Y; Yamamoto T
J Dermatol; 2013 Nov; 40(11):931-2. PubMed ID: 24112030
[No Abstract] [Full Text] [Related]
5. Amyotrophic lateral sclerosis developing during adalimumab therapy for psoriatic arthritis.
Bougea A; Anagnostou E; Stamboulis E; Kararizou E
Rev Neurol (Paris); 2014 Mar; 170(3):228-9. PubMed ID: 24656415
[No Abstract] [Full Text] [Related]
6. Severe eosinophilia during anti-tumor necrosis factor-alpha therapy for psoriatic arthritis.
Guidelli GM; Tenti S; Fioravanti A
Indian J Dermatol Venereol Leprol; 2014; 80(2):187-9. PubMed ID: 24685874
[No Abstract] [Full Text] [Related]
7. Erythema nodosum, a "red flag" during anti-TNF therapy.
Dalmau-Carolà J
Int J Rheum Dis; 2013 Aug; 16(4):493-4. PubMed ID: 23992277
[No Abstract] [Full Text] [Related]
8. [Cutaneous pseudolymphoma with two types of anti-TNFα: a class effect?].
Schmutz JL; Trechot P
Ann Dermatol Venereol; 2012 Oct; 139(10):695-6. PubMed ID: 23122389
[No Abstract] [Full Text] [Related]
9. Hypertriglyceridaemia during treatment with adalimumab in psoriatic arthritis.
Stinco G; Piccirillo F; Patrone P
Br J Dermatol; 2007 Dec; 157(6):1273-4. PubMed ID: 17916219
[No Abstract] [Full Text] [Related]
10. Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis.
Cheng AC; Chierakul W; Chaowagul W; Chetchotisakd P; Limmathurotsakul D; Dance DA; Peacock SJ; Currie BJ
Am J Trop Med Hyg; 2008 Feb; 78(2):208-9. PubMed ID: 18256414
[TBL] [Abstract][Full Text] [Related]
11. Malignancies developing in obese patients with psoriasis while on antitumour necrosis factor-α therapies: a case series.
Sadlier M; Lally A; Kirby B
Br J Dermatol; 2012 Oct; 167(4):937-8. PubMed ID: 22428935
[No Abstract] [Full Text] [Related]
12. Three years of methotrexate and secukinumab: Outcomes of psoriatic arthritis in a real-life setting.
Nicola S; Cassarino SG; Rolla G; Geronazzo G; Fornero M; Brussino L
J Am Acad Dermatol; 2022 Jan; 86(1):241-243. PubMed ID: 33549655
[No Abstract] [Full Text] [Related]
13. Miliary tuberculosis following negative latent tuberculosis infection screening prior to tumor necrosis factor-α antagonists: implications for management?
Teh BW; Street AC; McBryde ES; Denholm JT
J Rheumatol; 2012 Jun; 39(6):1297-8. PubMed ID: 22661422
[No Abstract] [Full Text] [Related]
14. Hyperpigmentation of the face following adalimumab treatment.
Blomberg M; Zachariae CO; Grønhøj F
Acta Derm Venereol; 2009; 89(5):546-7. PubMed ID: 19734995
[No Abstract] [Full Text] [Related]
15. Acute generalized skin eruption due to adalimumab: report of two cases.
Dalmau J; Roé E; Corella F; García-Navarro X; Peramiquel L; Alomar A
J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1105-6. PubMed ID: 17714134
[No Abstract] [Full Text] [Related]
16. Occurrence of penile intraepithelial neoplasia following adalimumab treatment for psoriatic arthritis.
Kreuter A; Meyer MF; Wieland U
Arch Dermatol; 2011 Aug; 147(8):1001-2. PubMed ID: 21844477
[No Abstract] [Full Text] [Related]
17. Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study.
Modesti V; Ramonda R; Ortolan A; Lorenzin M; Lo Nigro A; Frallonardo P; Oliviero F; Campana C; Punzi L
Scand J Rheumatol; 2012; 41(6):490-1. PubMed ID: 22985209
[No Abstract] [Full Text] [Related]
18. Lichenoid reaction induced by adalimumab.
De Simone C; Caldarola G; D'Agostino M; Rotoli M; Capizzi R; Amerio P
J Eur Acad Dermatol Venereol; 2008 May; 22(5):626-7. PubMed ID: 18005023
[No Abstract] [Full Text] [Related]
19. Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis.
Wu P; Huang C; Liao PF; Ruperto N; Zeng H
Int J Rheum Dis; 2023 Nov; 26(11):2119-2121. PubMed ID: 37563978
[No Abstract] [Full Text] [Related]
20. Management of recurrent cutaneous abscesses during therapy with infliximab.
De Simone C; Murri R; Maiorino A; Venier A; Caldarola G
Clin Ther; 2011 Dec; 33(12):1993-6. PubMed ID: 22088412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
